Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease.
about
Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disordersSystematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C
P2860
Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Outcome of Combination Therapy ...... Chronic Type C Liver Disease.
@en
type
label
Outcome of Combination Therapy ...... Chronic Type C Liver Disease.
@en
prefLabel
Outcome of Combination Therapy ...... Chronic Type C Liver Disease.
@en
P2093
P356
P1433
P1476
Outcome of Combination Therapy ...... Chronic Type C Liver Disease.
@en
P2093
Hirokazu Chishina
Hiroshi Ida
Kazuomi Ueshima
Masahiro Takita
Mina Iwanishi
Naoshi Nishida
Satoru Hagiwara
Tadaaki Arizumi
Tomohiro Minami
Tomohiro Watanabe
P356
10.1159/000451010
P478
92 Suppl 1
P577
2016-12-15T00:00:00Z